Clinical trial
A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir…
NCT00281606 · University of California, San Diego, Other · Completed
Key facts
| NCT number | NCT00281606 |
|---|---|
| Title | A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules |
| Official title | A Phase IV, Randomized, Open-label Study of the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules |
| Lead sponsor | University of California, San Diego, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | Different formulations of once-daily lopinavir/ritonavir |
| Enrollment | 65 |
| Start date | Feb 14, 2006 |
| Primary completion | Oct 16, 2007 |
| Completion | Jun 13, 2012 |
| First posted | Jan 25, 2006 |
| Last update posted | Jun 30, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: